COMMUNIQUÉS West-GlobeNewswire

Rexahn and BioSense Global Announce Collaboration and License Agreement for RX-3117 in Greater China
16/04/2019
ROCKVILLE, Md. and SUZHOU, China, April 16, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage, biopharmaceutical company focused on oncology, and BioSense Global LLC, a New [...]
AMAG Pharmaceuticals Appoints Nancy Griffith, PH.D., as Vice President of Scientific Communications and Medical Operations
16/04/2019
WALTHAM, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Nancy Griffith, Ph.D., as vice president, scientific communications and medical operations, [...]
Intra-Cellular Therapies Mourns the Passing of Co-Founder and Nobel Laureate, Dr. Paul Greengard
16/04/2019
NEW YORK, April 16, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, mourns the [...]
IntelGenx Files Non-Provisional U.S. Patent Application for Oil-Based Active Ingredients
16/04/2019
SAINT LAURENT, Quebec, April 16, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that it has filed a new non-provisional patent [...]
Profound Medical Announces First-of-its-Kind TULSA-PRO® Installation
16/04/2019
- First Prostate Cancer Treatment Using TULSA-PROÒ and Philips’ New Elition MR Performed in Trier, Germany - TORONTO, April 16, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “ [...]
Entasis Therapeutics Announces the Appointment of Elizabeth Keiley as General Counsel
16/04/2019
WALTHAM, Mass., April 16, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
aTyr Pharma to Host Inaugural Summit Meeting on Neuropilin-2 (NRP-2) Biology
16/04/2019
Meeting to feature presentations on recent NRP-2-related discoveries by leading research experts in the field SAN DIEGO, April 16, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company [...]
Zimmer Biomet and RTI Surgical® Partner with AAID Foundation to Expand Access to Dental Care for Veterans
16/04/2019
Partnership reinforces shared commitment of Zimmer Biomet and RTI to improve the lives of patients and meet the needs of deserving veterans PALM BEACH GARDENS, Fla., April 16, 2019 (GLOBE NEWSWIRE) -- Zimmer Biomet and [...]
MediPharm Labs Announces DTC Eligibility, Increasing Accessibility for US Investors
16/04/2019
TORONTO, April 16, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
À l'occasion de l'assemblée générale annuelle de l'American Society of Gene and Cell Therapy, Abeona Therapeutics présentera des données pour ABO-401 relatives à la fibrose kystique et aux troubles rétiniens
16/04/2019
De nouvelles données facilitant les demandes d'investigation sur un nouveau médicament pour l'ABO-202 dans le cas de la maladie CLN1 seront également mises en avant NEW YORK et CLEVELAND, 16 avr. 2019 (GLOBE NEWSWIRE [...]
BioSig Completes Successful Patient Cases at Greenville Memorial Hospital
16/04/2019
Second Center to Report Positive Clinical Experience with PURE EP(tm) System Santa Monica, CA, April 16, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]
VIVUS to Host First Quarter Business Update and Financial Results Conference Call on Tuesday, April 30, 2019
16/04/2019
CAMPBELL, Calif., April 16, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) today announced that it will report financial results and provide a business update for the first quarter of 2019 after the market close on [...]
Aleafia Health to add 50,000 kg Extraction Capacity at Paris, ON Facility
16/04/2019
Company Expecting to Complete Phase II Expansion in Q3 2019 TORONTO, April 16, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) will add 50,000 kg [...]
Kamada announces FDA acceptance of Inhaled AAT program path forward
16/04/2019
Company intends to submit an IND to the FDA and a CTA to the EMA, and expects to initiate the Inhaled AAT Phase 3 pivotal study during the second half of 2019 REHOVOT, Israel, April 16, 2019 (GLOBE NEWSWIRE) -- Kamada [...]
Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design
16/04/2019
Data to be presented today at 2019 Muscular Dystrophy Association Clinical and Scientific Conference Phase 2/3 clinical trial for suvodirsen in DMD expected to initiate in July 2019 Interim efficacy data from ongoing [...]
EyePoint Pharmaceuticals to Present at Upcoming Medical Conferences
16/04/2019
Two Presentations Highlighting YUTIQ™ to be Presented at the 2019 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Data from Two Phase 3 Studies of DEXYCU ™ to be presented at the 2019 American [...]
CureVac Granted Patent Claiming the Combination of mRNA Vaccines with Anti-PD-L1 Antibodies
16/04/2019
PD-L1 Pathway Now Covered as New Patent Complements the mRNA/Anti-PD-1 Antibodies Combination Patent Granted in July 2017 TÜBINGEN, Germany and BOSTON, April 16, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated [...]
Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates
16/04/2019
RUTHERFORD, N.J., April 16, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics, molecular markers and data [...]
Axovant Announces Upcoming Presentations at the Annual Meeting of the American Society of Gene and Cell Therapy
16/04/2019
-Details from ongoing SUNRISE-PD Phase 2 trial of AXO-Lenti-PD and the AXO-AAV-GM2 program to be featured in oral presentations- -Preclinical data from AXO-AAV-GM1 program to be highlighted in poster presentation- BASEL [...]

Pages